Kenvue Inc. Common Stock (KVUE)
20.74
-0.07 (-0.34%)
![](https://g.foolcdn.com/editorial/images/805311/gettyimages-1443467748-1200x766-1056b8b-1.jpg)
Via The Motley Fool · February 4, 2025
![](https://g.foolcdn.com/editorial/images/805493/child-receiving-a-vaccination-shot-from-a-healthcare-professional.jpg)
Via The Motley Fool · February 1, 2025
![](https://g.foolcdn.com/editorial/images/804425/gettyimages-592647720-1201x740-237672e.jpg)
Via The Motley Fool · January 21, 2025
![](https://g.foolcdn.com/editorial/images/803379/getty-dividend-stocks-growing-money-income-cash-3.jpg)
These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors.
Via The Motley Fool · January 17, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/17/Display-Of-Stock-Market-Quotes-With-City.jpeg?width=1200&height=800&fit=crop)
Activist investor Starboard Value LP has reportedly acquired a 7.7% stake worth approximately $500 million in Qorvo Inc. on Thursday, targeting the struggling semiconductor manufacturer for potential operational changes.
Via Benzinga · January 17, 2025
![](https://cdn.pixabay.com/photo/2017/08/30/07/56/money-2696228_960_720.jpg)
The following 10 one decision stocks have increased their dividends for over 25 years, making them Dividend Aristocrats.
Via Talk Markets · January 15, 2025
![](https://g.foolcdn.com/editorial/images/802255/gettyimages-902863704-1201x801-d21b45d.jpg)
Investing by equal parts in these three dividend stocks produces an average yield of 3%.
Via The Motley Fool · December 29, 2024
![](https://images.pexels.com/photos/3823493/pexels-photo-3823493.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
Conservative retirement investing is all about creating passive income with quality securities, held for the long-run.
Via Talk Markets · December 29, 2024
![](https://g.foolcdn.com/editorial/images/801656/gettyimages-1686497935.jpg)
Via The Motley Fool · December 23, 2024
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 12, 2024
![](https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp)
With a solid technical rating of 8 out of 10, KENVUE INC (NYSEKVUE) is showing strong indications of a possible breakout.
Via Chartmill · November 18, 2024
![](https://g.foolcdn.com/editorial/images/794756/investor-sofa-laptop-getty.jpg)
The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.
Via The Motley Fool · October 25, 2024
![](https://g.foolcdn.com/editorial/images/799838/gettyimages-1236903031-1200x800-5b2df79-1.jpg)
Via The Motley Fool · December 8, 2024
![](https://g.foolcdn.com/editorial/images/799476/home-apartment-rental-real-estate-cleaning-1200x800-5b2df79.jpg)
These three dividend-paying companies have all raised their payouts every year for at least 40 consecutive years.
Via The Motley Fool · December 4, 2024
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
KVUE earnings call for the period ending September 30, 2024.
Via The Motley Fool · November 7, 2024
![](https://cdn.benzinga.com/files/images/story/2024/11/08/FDA-Shutterstock.jpeg?width=1200&height=800&fit=crop)
FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued.
Via Benzinga · November 8, 2024
![](https://cdn.benzinga.com/files/images/story/2024/11/07/Le-azioni-di-Kenvue--produttore-di-Liste.jpeg?width=1200&height=800&fit=crop)
Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in Skin Health and Beauty.
Via Benzinga · November 7, 2024
![](https://g.foolcdn.com/editorial/images/795336/two-investors-consider-a-laptop.jpg)
Can tinkering around the edges actually make this stock more attractive?
Via The Motley Fool · October 30, 2024
![](https://g.foolcdn.com/editorial/images/794368/getty-dividend-income.jpg)
While tech-based growth stocks might seem like the right play, you can't ignore dividends if you want to have a strong portfolio.
Via The Motley Fool · October 27, 2024
![](https://g.foolcdn.com/editorial/images/794813/pharmacy-drug-store-shopping-sick.jpg)
Ken Griffin's Citadel just added 18 million shares of an under-the-radar consumer health stock.
Via The Motley Fool · October 26, 2024
![](https://g.foolcdn.com/editorial/images/795000/gettyimages-1329442019-1200x800-5b2df79.jpg)
An activist investor is taking a stake in Kenvue stock.
Via The Motley Fool · October 26, 2024